Insulin-like growth factors I and II (IGF I and II) are polypeptides with both growth-promotin$ and insulin-like metabolic effects 16"27. Immunorea~ive IGF I is present in the retina t4 and both IGF I and II are present ~ vitreal fluid 12. The type I and type II IGF receptors are a~o localized withi~ the neural retina 3a5"2°'33. The presence of IGFs and IGF receptors within the eye suggests a possible growth-promotir~g e~f~.ct of IGFs on ocular tissues. IGF may enter the eye from the blood or, ~iternatively, arise from an ocular cell type which synthesizes and secretes IGF. IGF I and II mRNA synthesis in scleral ceils ~3 and IGF I synthesis in rat retina 14 suggests endogenous IGF productit~n in the eye. We hypothesized that IGFs and IGF receptors are synthesized by one ocular cell type, the retinal pigment-epithelium (RPE). As a first step in studying IGF production by the RPE, we analyzed expression of the IGF and IGF receptor genes by cultured human RPE cells. Using Northern analysis, RNase protection and reverse-transctSptase polymerase chain reaction (RT-PCR), we found that cultured RPE cells synthesize mRNA for IGF I and the type I and type 1I IGF receptors.
INTRODUCTION
Insulin-like growth factors I and II (IGF Iard IGF II) are polypeptides which share structural homology with proinsulin and exert mitogenic and growth-promoting effects in many tissues 16'27 . IGF I and IGF II bind to specific membrane receptors, the type I and type II IGF receptors, respectively 7'22'~. In the eye, autoradiography ;,2°, immunocytochemistry 2° and affinity labelling 15' 2o.33 have localized both the type I and II IGF receptors to the neural retina and retinal pigment epithelium (RPE). IGF I and II immunoreactivity are present in the vitreous n, whereas only IGF I immunoreactivity is present in the retina and RPE u. Because the RPE, located adjacent to the choriocapillaris, is responsible for the active transport of ions, metabolites and fluid to the inner retina 37, IGF I immunostaining may reflect RPE internalization of circulating IGFs. Alternatively, IGF I immunoreactivity could reflect endogenous growth factor production. In vitro conditioned medium from cultured human RPE contains IGF I immunoreact-ivitv 34, implying either release of internalized IGF I, as seea in endothelial cell cultures 2, or endogenous IGF I production by RPE.
As an initial approach to understanding whether ocular IGF I and II represent internalized or newly synthesized growth factors, we determined whether cultured human RPE cells express th~ genes for IGF I and II and their receptors. Because there are differences in the sensiti,Aty of various assays and we were interested in the relative gene expression levels, we used three independent methods to assay levels of cellular mRNAs for the IGF and IGF receptor genes: Northern analysis, ribcnuclease (RNase) protection and reverse-transcriptase polymerase chain reaction (RT-PCR), listed in order of increasing sensitivity t7,26. Using these methods, we have detected IGF I, type I and type II IGF receptor mRNA in cultured human RPE cells. Our data provide a basis for analyzing the regulation and expression of these genes in human RPE cells, a key cell type in ocular health and disease.
MATERIALS AND METHODS

Chemicals
Minimum essemial medium (MEM) and PJ'MI 1640 medium were purchased from Grand Island Biological Co. (Grand Island NY). Improved minimum essential medium (IMEM) was obtained ~ora Biofiuids (RockviUe, MD) and bovine calf serum (CS) from Hycione Labs (Logan, Lrl'). Tissue culture supplies were purchased from Costar (Cambridge, MA) and Coming Glass Works (Corning, NY) Molecular biology grade reagents were purchased from 
Cell c:~lture
Retinal pigment epithelia were isolated from human post-mortem eyes provided by the Michigan Eye Bank. Primary RPE cell cultures were estabfished as previously described s. Cells were periodically subcuitured at a density of 3-5 x 106 cells per 75 cm 2 tissue culture flask in MEM containing 20% CS. Ceils were maintained at 37 °(3 in a humidified atmosphere of 5% CO2 and 95% 0 2. Medium was changed 3 times weekly.
Breast cancer cell line MD,~-MB231 was obtained from American Type Culture Collection (ATCC, Rockville, MD) and maintained in IMEM with 10% CS. The human neuroblastoma cell line SK-N-SH was obtained from J. Biedler, Memorial Sloan-Kettering Institute (New York, NY) and maintained in RPMI 1640 medium with 10% fetal CS.
Northern analysis
Total cellular RNA was isolated from cells or tissues by guanidinium thiocyanate-phenol extraction s. Poly(A) + and poly(A) RNA were selected by oligo(dT) cellulose chromatography following the manufacturer's protocol (Pharmacia, Gaithersburg, MD) 1. The hut, ran IGF IA cDNA was kindly provided by Dr. Peter S. RNA samples (1-10/~g) were d.;ssolved in 37.5% formamide, 1.6 M formaldehyde and 1.5 mM sc, dium phosphate buffer. RNA samples were electrophoresed in denaturing gels (1% agarose, 2.2 M formaldehyde, 0.02 M sodium phosphate buffer) and transferred to Nytran nylon membranes (Schleicher & Schuell, Keene, NH) by capifiary blotting. After transfer, 40-100 ng of denatured IGF I and IGF II cDNA were applied to the membrane for positive and negative hybridization efficiency controls. Nucleic acids were baked o~to membranes for 30 min at 65-80 °C. Membranes were hybridized in 40% formamide, 1.1 M NaCl, 60 mM NaH2PO4, 6 mM EDTA, 1.0% sodium dodecyl sulfate (SDS), 10% dextran sulfate, 100-200/~g/ml denatured salmon DNA and 32p-labeUed cDNA probe (I-5 × I05 cpm/mi) for 12-16 h at 42 °C. Membranes were washed twice for 15 min in 0.36 M NaCI, 20 mM NaH2PO4, 2 mM EDTA and 0.1% SDS at room temperature and twice for 15 min at 65 °(3 in 90 mM NaCl, 5 mM NaH2PO4, 0.5 mM EDTA and 0.1% SDS. For high stringency, membranes were washed twice for 15 min at 65 °(3 in 18 mM NaCI, 1 mM NaH2PO 4, 0.1 mM EDTA and 1.0% SDS. Membranes were exposed to X-ray film (Kodak) in the presence of an intensifying screen at -70 °(3 for 1-7 days. mal cycler for 40 cycles, using the PCR cycle profile recommended by the Taq DNA polymerase manufacturer. The sequences of oligonucleotide primers used are outlined in Table I . Primers were constructed to conserve regions between rat and human sequences ~' ~.=. To eliminate the possibility of DNA contamination, primers spanned intronic sequences ~'~. After PCR, 20/d afiquots were electrophoresed in a 1% agarose gel containing 0.4/~g/n~! etMdium bromide in 1 × TBE buffer as described ~9.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNase p~otection assay
All riboprobes were synthesized from cDNA templates according to the manufacturer's protocol (Promega, E~ch RNA sample (10-.50/~g) was hybridized overnight at 50 °(7, v,~th 5 ~ 104 cpm probe lit 30//1 buffer containing 80% formamide, 40 mM pipegazine-N,N'bis(2-ethanesulfonic acid), 0.4 M NaCI and 1 mM EDTA. Samples were s~tbsequently digested with 40 pg/ml RNase A (Sigma) for 30 rnin at 25 °C. Digestion was terminated with proteinase K and SDS. The samples w¢,'e ¢,:~racted with phenol and then precipitated at -70 °C with 10 ~g tRNA and two volumes of absolute ethanol. Pellets were res~spended in 5 ?~! ,f 80% formamide loading buffer and run on a 6% poly~crylamide, 8 M urea sequencing gel. Size markers were ~epared by end-labeling MspI,cfigested fragment~, of pBR322 (New England Biolabs, Beverly, MA). The gels were dried and exposed to X-ray film in the 2323-1929-1264-702 -224 - Fig. 2 . RT-PCR analysis of RNA in cultured human RPE celia;. One/tg of total cellular RNA was reverse transcribed followed by PCR for 40 cycles with the primers for either IGF I or IGF H. Sterile H20 was added instead of RNA in control reactions; all other conditions remained constant. The PCR products were separated by agarose gel elec~ophoresis and visualized with ethidium bronEde. A: the IGF I primers produced the expected 366-bp product in RPE cells and rat liver but not m cc~trol reaction. B: the IGF II pn~ers produced the expected 249-bp ~agment in rat muscle but not in RPE cells.
presence of an intensifying screen at -70 °C for 1-3 days.
RESULTS
IGF gone expression
We were unable to detect IGF I or IGF Ii mRNA in cultured human RPE cells using Northern analysis of 5 /tg poly(A) + RNA (results not shown). By RNase protection analysis, 30/~g of total cellular liver RNA Frotected a 182-bp fragment of the ~GF I exon 3 probe, whereas RPE RNA protected no visible fragments (Fig.  1A) . The neuroblastoma cell line SK-N-SH protected a 580-blp fragment of the 854-bp IGF II probe in RNase protection assay (Fig. 1B) . This cell line has been described to expxess large amounts of IGF II mRNA 35. The 580-bp protected fragment was smaller than the probe because the IGF II transcipt produced by neuroblastoma cell lines does not contain exons 1, 2 and 3 seen in adult liveP ~. In contrast, RPE RNA did not protect the 854-bp IGF II probe.
RT-PCR amplified the predicted IGF I 366-bp product from rat liver and RPE RNA but not from the control water sample (Fig. 2A) . The expected IGF II 249-bp product was amplified in rat muscle but not in RPE (Fig.  2B) or a control water samp!e (results not shown).
1GF receptor gene expression
Northern hybridization of total RNA (20/~g) with a 32p-labelled 1247-bp cDNA probe for type I IGF receptor detected 7-kb and 11-kb transcripts in RPE (Fig. 3A,  B) . The ll-kb hybridization band was of higher intensity than the 7-kb band, suggesting that the ll-kb mRNA is the major transcript produced by RPE. In RNase protection analysis experiments, RPE RNA protected three fragments of the 293-bp type I IGF receptor cDNA (Fig.  4A) . MDA-MB231 RNA protected these same three fragments of the 293-bp type I IGF receptor cDNA: the complete 293-bp fiagment, a 200-bp fragment end an 90-bp fragment. This pattern of expression results from alternative splicing of tt~e type I IGF receptor gene 36. RPE RNA also protected the complete 377-bp BamHIBamHI fragment oi type ii IGF receptor probe (Fig.  4B) . The les~ intense, smaller bands are due to the hybridization between sample RNA and fragments of riboprobe synthesized at less than full template length. These bands represent, therefore, an artifact of incomplete probe synthesis and not unique cellular RNAs.
DISCUSSION
The purpose of this study was to determine if cultured human RPE cells express the genes for IGF I and II a~,d their corresponding receptors. We found low levels of IGF I gene expression detectable only by RT-PCR and not by RNase protection or Northern blotting. Further investigation will be required to prove that these transcripts are translated into IGF I peptide, but the presence of IGF I mRNA transcripts argues for endogenous IGF I production. The presence of RPE IGF I immunoreactivity both in vitro and in vivo support this tenet 34.
In contrast to IGF I, type I IGF receptor mRNA was detected both by Northern blotting and RNase protection. Because Northern analysis is 100-fold less sensitive than RNase protection 26, which in turn is less sensitive than RT-PCR ~7, our data suggest that type I IGF receptor mRNA is more abundant in cultured human RPE cells than IGF I mRNA (detectable only by RT-PCR). Northern analysis for the type I IGF receptor revealed 7-kb and l l-kb mRNA transcripts in RPE. This transcript profile is identical to the original hybridization pattern reported by Ullrich and coworkers in 3T3-LI fibroblasts and adipocytes 32. RNase protection of RPE RNA for the type I IGF receptor protected three fragments: 293 bp, 200 bp and 90 bp. This protection pattern has been reported in the breast cancer cell line MDA-MB 231 where neither increasing amounts of RNase nor changing the time or temperature of the RNase digestion had an effect on the three fragments and is due to alternative splicing of the type I IGF receptor gene 36.
Co-expression of IGF I and IGF I receptor genes by cultured RPE cells suggests at, autocrine role for IGF I on RPE~ IGF I, acting t~rough its receptor, may serve as a survival factor for human RPE in vitro, s~milar to the role of basic fibroblast growth factor in maintaining photoreceptors ~J. IGF I may represent one of the active factors present in RPE-conditioned medium, which stimulates photoreceptor differentiation and Mfiller cell prolife~ation 3°. Alternatively, the low level of gene expression of IGF 1 compared to the type I IGF receptor may imply a paracrine role for circulating IGF I. In retinal endothelial cells, binding of circulating IGF I increases DNA synthesis and regulates endothelial cell chemotaxis ts'~9. Additional experiments examining IGF I mRNA translation into protein may clarify the primary mode of action of IGF I in RPE.
We found no IGF II gene expression in cultured human RPE cells. While present in fetal sclera and cornea t3, no adult ocular source has been reported 27, suggesting that adult vitreal IGF II immunoreactivity arises from circulating IGF II n. 
